Drug Type Small molecule drug |
Synonyms Wild Baicalin |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization- |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC21H18O11 |
InChIKeyIKIIZLYTISPENI-ZFORQUDYSA-N |
CAS Registry21967-41-9 |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Hepatitis | China | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute Lung Injury | Preclinical | China | 01 Oct 2025 | |
| Acute kidney injury due to sepsis | Preclinical | China | 12 Jun 2025 | |
| Liver Diseases, Alcoholic | Preclinical | China | 13 May 2025 | |
| Immune-mediated uveitis | Preclinical | China | 12 May 2025 | |
| influenza A subtype H9N2 infection | Preclinical | China | 08 May 2025 | |
| Lung Cancer | Preclinical | China | 05 May 2025 | |
| Lung Cancer | Preclinical | China | 05 May 2025 | |
| Lung Cancer | Preclinical | China | 05 May 2025 | |
| Lung Cancer | Preclinical | China | 05 May 2025 | |
| Multiple Sclerosis | Preclinical | China | 01 May 2025 |





